ZANUBRUTINIB

ZANUBRUTINIB was reported 4539 times

ZANUBRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTOKINE INCREASED 56 0.4148
1 TYROSINE KINASE MUTATION 5 0.2000
2 FOLLICULAR LYMPHOMA RECURRENT 14 0.1750
3 MARGINAL ZONE LYMPHOMA RECURRENT 5 0.1042
4 ACQUIRED C1 INHIBITOR DEFICIENCY 2 0.0952
5 MANTLE CELL LYMPHOMA RECURRENT 34 0.0782
6 LYMPHOMA TRANSFORMATION 24 0.0667
7 KARYOTYPE ANALYSIS ABNORMAL 6 0.0550
8 UVEAL MELANOMA 3 0.0536
9 BING-NEEL SYNDROME 2 0.0513
10 CONJUNCTIVAL DISCOLOURATION 6 0.0492
11 POLYCHROMASIA 13 0.0433
12 BLOOD IMMUNOGLOBULIN M INCREASED 26 0.0428
13 TP53 GENE MUTATION 4 0.0412
14 ORAL BLOOD BLISTER 8 0.0400
15 SPLENIC MARGINAL ZONE LYMPHOMA 3 0.0395
16 HAEMATOTYMPANUM 3 0.0353
17 BLOOD IMMUNOGLOBULIN G ABNORMAL 5 0.0299
18 PERINEAL ULCERATION 4 0.0286
19 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 37 0.0263
20 RENAL ISCHAEMIA 14 0.0256
21 HYPERVISCOSITY SYNDROME 7 0.0243
22 DISSEMINATED MUCORMYCOSIS 9 0.0228
23 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 5 0.0216
24 BLOOD IMMUNOGLOBULIN G DECREASED 49 0.0198
25 BLOOD IMMUNOGLOBULIN M ABNORMAL 2 0.0194
26 LYMPHOCYTE COUNT ABNORMAL 21 0.0187
27 DISSEMINATED ASPERGILLOSIS 8 0.0169
28 PARAPROTEINAEMIA 5 0.0161
29 MANTLE CELL LYMPHOMA 23 0.0151
30 ECTHYMA 6 0.0150
31 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 14 0.0148
32 BLOOD CHOLINESTERASE DECREASED 4 0.0146
33 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 10 0.0143
34 BULLOUS HAEMORRHAGIC DERMATOSIS 3 0.0143
35 BASOSQUAMOUS CARCINOMA 2 0.0134
36 BONE LESION EXCISION 2 0.0132
37 INCREASED NEED FOR SLEEP 3 0.0129
38 HAEMORRHAGE SUBCUTANEOUS 45 0.0127
39 GASTROINTESTINAL FUNGAL INFECTION 6 0.0117
40 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 2 0.0113
41 ACINETOBACTER TEST POSITIVE 2 0.0103
42 GRANULOCYTE COUNT DECREASED 18 0.0097
43 VITH NERVE PARALYSIS 11 0.0096
44 HYPHAEMA 5 0.0096
45 EOSINOPHILIC CELLULITIS 2 0.0094
46 DYSPLASIA 11 0.0092
47 FOLLICULAR LYMPHOMA 8 0.0091
48 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 20 0.0091
49 BLOOD IMMUNOGLOBULIN M DECREASED 9 0.0090
50 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 2 0.0087
51 HYPOPROTEINAEMIA 16 0.0084
52 MINIMAL RESIDUAL DISEASE 4 0.0083
53 DYSCALCULIA 2 0.0081
54 HYPOALBUMINAEMIA 62 0.0080
55 LYMPHOCYTOSIS 17 0.0079
56 HYPOPHOSPHATAEMIA 58 0.0078
57 CHEST WALL HAEMATOMA 2 0.0078
58 BLOOD URIC ACID ABNORMAL 3 0.0074
59 CHRONIC LYMPHOCYTIC LEUKAEMIA 34 0.0072
60 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 6 0.0071
61 MYELOSUPPRESSION 254 0.0070
62 BLADDER HYPERTROPHY 3 0.0068
63 HYPERLEUKOCYTOSIS 6 0.0068
64 CEREBRAL ASPERGILLOSIS 4 0.0065
65 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0065
66 H1N1 INFLUENZA 9 0.0064
67 SKIN NEOPLASM EXCISION 5 0.0064
68 MYOCARDIAL INJURY 7 0.0062
69 CANDIDA PNEUMONIA 2 0.0062
70 DRAINAGE 3 0.0061
71 BLOOD VISCOSITY DECREASED 2 0.0060
72 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
73 FEBRILE INFECTION 7 0.0059
74 FAECAL VOLUME INCREASED 3 0.0058
75 POSITRON EMISSION TOMOGRAM ABNORMAL 4 0.0057
76 UTERINE INFECTION 3 0.0057
77 LYMPHOCYTE COUNT DECREASED 100 0.0057
78 SCROTAL OEDEMA 4 0.0056
79 VASOGENIC CEREBRAL OEDEMA 4 0.0056
80 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 21 0.0055
81 INTERLEUKIN LEVEL INCREASED 3 0.0054
82 PETECHIAE 56 0.0054
83 URINARY TRACT INFECTION FUNGAL 3 0.0052
84 URETERIC OBSTRUCTION 7 0.0051
85 HYPOCHLORAEMIA 6 0.0051
86 VITRECTOMY 3 0.0050
87 HYPOGAMMAGLOBULINAEMIA 33 0.0050
88 RETICULOCYTE COUNT INCREASED 4 0.0049
89 LYMPHOCYTE COUNT INCREASED 16 0.0049
90 ABDOMINAL MASS 13 0.0048
91 LABELLED DRUG-DRUG INTERACTION ISSUE 7 0.0048
92 CYTOKINE RELEASE SYNDROME 94 0.0047
93 BLOOD BLISTER 14 0.0045
94 HEAD AND NECK CANCER 3 0.0044
95 BLOOD LACTATE DEHYDROGENASE ABNORMAL 3 0.0044
96 HYPERURICAEMIA 18 0.0044
97 ECCHYMOSIS 30 0.0044
98 CENTRAL NERVOUS SYSTEM LYMPHOMA 6 0.0044
99 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
100 TUMOUR LYSIS SYNDROME 37 0.0042
101 HAEMOTHORAX 12 0.0041
102 BLOOD URIC ACID DECREASED 2 0.0041
103 INCREASED TENDENCY TO BRUISE 37 0.0040
104 SPONTANEOUS HAEMORRHAGE 4 0.0039
105 MUCORMYCOSIS 10 0.0038
106 SOFT TISSUE INFECTION 7 0.0038
107 SERUM FERRITIN INCREASED 20 0.0038
108 HYPOMAGNESAEMIA 52 0.0037
109 BASAL GANGLIA HAEMORRHAGE 3 0.0037
110 PENILE HAEMORRHAGE 3 0.0037
111 NEUTROPHIL COUNT DECREASED 149 0.0037
112 SPLENIC RUPTURE 6 0.0036
113 KLEBSIELLA SEPSIS 4 0.0035
114 PNEUMONIA FUNGAL 14 0.0035
115 INVESTIGATION ABNORMAL 5 0.0035
116 HEPATITIS B REACTIVATION 11 0.0035
117 EAR HAEMORRHAGE 7 0.0035
118 SYSTEMIC MYCOSIS 4 0.0034
119 MULTIMORBIDITY 4 0.0033
120 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
121 SCROTAL SWELLING 3 0.0032
122 INTERVERTEBRAL DISCITIS 6 0.0032
123 LYMPHOEDEMA 22 0.0032
124 INTRACRANIAL MASS 3 0.0032
125 SUBCUTANEOUS HAEMATOMA 4 0.0031
126 TELANGIECTASIA 3 0.0031
127 RED BLOOD CELLS URINE POSITIVE 3 0.0031
128 ANIMAL SCRATCH 3 0.0031
129 BLOOD IMMUNOGLOBULIN A DECREASED 2 0.0031
130 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2 0.0030
131 EFFUSION 4 0.0029
132 CYTOKINE STORM 2 0.0029
133 IMMUNOGLOBULINS DECREASED 4 0.0029
134 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
135 HYPOCALCAEMIA 54 0.0029
136 HAEMORRHAGIC DIATHESIS 10 0.0028
137 GASTROINTESTINAL TUBE INSERTION 7 0.0028
138 HYPERPHOSPHATAEMIA 6 0.0028
139 LISTLESS 9 0.0027
140 LYMPH NODE PAIN 5 0.0027
141 DISEASE PROGRESSION 318 0.0027
142 INFECTIOUS PLEURAL EFFUSION 4 0.0026
143 ASPIRATION PLEURAL CAVITY 2 0.0026
144 MUCOSAL HAEMORRHAGE 3 0.0026
145 GASTROSTOMY 4 0.0026
146 ENDOCARDITIS BACTERIAL 2 0.0025
147 DIARRHOEA INFECTIOUS 2 0.0025
148 BRONCHIAL CARCINOMA 2 0.0025
149 CONTUSION 241 0.0025
150 PROSTATIC OPERATION 3 0.0025
151 BLEEDING TIME PROLONGED 3 0.0025
152 SECONDARY IMMUNODEFICIENCY 3 0.0025
153 FEBRILE CONVULSION 3 0.0025
154 CAPILLARY LEAK SYNDROME 5 0.0024
155 LYMPHADENOPATHY 85 0.0024
156 HYPERAESTHESIA TEETH 3 0.0024
157 PURPURA 21 0.0024
158 PRESCRIBED UNDERDOSE 47 0.0024
159 WHITE BLOOD CELL COUNT ABNORMAL 15 0.0023
160 SPLENOMEGALY 27 0.0023
161 WHITE BLOOD CELL COUNT DECREASED 247 0.0023
162 PHARYNGEAL ULCERATION 3 0.0023
163 PNEUMONIA VIRAL 7 0.0022
164 BONE CONTUSION 2 0.0022
165 RED BLOOD CELL COUNT INCREASED 6 0.0022
166 SQUAMOUS CELL CARCINOMA OF SKIN 13 0.0022
167 ANAL HAEMORRHAGE 6 0.0021
168 SKIN INFECTION 24 0.0021
169 NASAL OBSTRUCTION 4 0.0021
170 C-REACTIVE PROTEIN INCREASED 77 0.0021
171 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
172 ENTEROCOCCAL INFECTION 10 0.0021
173 PLATELET COUNT DECREASED 219 0.0021
174 HYPOKALAEMIA 94 0.0020
175 DENTAL OPERATION 5 0.0020
176 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
177 DILATED CARDIOMYOPATHY 2 0.0020
178 ENDODONTIC PROCEDURE 5 0.0020
179 VASCULAR RUPTURE 3 0.0019
180 URINARY BLADDER HAEMORRHAGE 4 0.0019
181 COVID-19 PNEUMONIA 22 0.0019
182 PROTEIN TOTAL DECREASED 7 0.0019
183 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 11 0.0019
184 EPSTEIN-BARR VIRAEMIA 2 0.0018
185 CYTOPENIA 22 0.0018
186 CARDIOTOXICITY 16 0.0018
187 MOUTH HAEMORRHAGE 13 0.0018
188 ATRIAL FLUTTER 14 0.0018
189 BLOOD FIBRINOGEN DECREASED 2 0.0018
190 CHEMICAL BURN 2 0.0017
191 HERPES VIRUS INFECTION 10 0.0017
192 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
193 CARDIAC TAMPONADE 8 0.0017
194 COLON OPERATION 2 0.0017
195 PRODUCT USE COMPLAINT 26 0.0016
196 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
197 HAEMATOLOGICAL INFECTION 4 0.0016
198 PNEUMONIA BACTERIAL 15 0.0016
199 OPPORTUNISTIC INFECTION 3 0.0016
200 CATHETER PLACEMENT 3 0.0016
201 WHITE BLOOD CELLS URINE POSITIVE 3 0.0016
202 ENDOCARDITIS 8 0.0016
203 DIFFUSE LARGE B-CELL LYMPHOMA 12 0.0016
204 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
205 DACRYOSTENOSIS ACQUIRED 2 0.0015
206 ASPERGILLUS INFECTION 10 0.0015
207 SKIN INJURY 5 0.0015
208 CALCULUS BLADDER 2 0.0015
209 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
210 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
211 CARDIOVERSION 2 0.0014
212 LUNG ABSCESS 3 0.0014
213 ATRIAL TACHYCARDIA 3 0.0014
214 ENDOTRACHEAL INTUBATION 4 0.0014
215 EYE CONTUSION 3 0.0014
216 NECK MASS 4 0.0014
217 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
218 ESCHERICHIA SEPSIS 4 0.0014
219 CARDIAC FIBRILLATION 2 0.0014
220 HAEMOLYTIC ANAEMIA 12 0.0013
221 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
222 DISEASE COMPLICATION 6 0.0013
223 ASPARTATE AMINOTRANSFERASE INCREASED 69 0.0013
224 ANAEMIA 247 0.0013
225 LYMPHOMA 20 0.0013
226 ORAL INFECTION 5 0.0013
227 PROCEDURAL HAEMORRHAGE 5 0.0013
228 CYSTITIS INTERSTITIAL 2 0.0012
229 WRONG DOSE 3 0.0012
230 ACUTE LEUKAEMIA 2 0.0012
231 CRYPTOCOCCOSIS 2 0.0012
232 INTERNAL HAEMORRHAGE 14 0.0012
233 HYPERNATRAEMIA 6 0.0012
234 SKIN LESION 33 0.0012
235 ERYSIPELAS 6 0.0012
236 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
237 AMYLOIDOSIS 2 0.0012
238 RED BLOOD CELL COUNT DECREASED 33 0.0012
239 ATRIAL FIBRILLATION 112 0.0011
240 SKIN HAEMORRHAGE 17 0.0011
241 EXTREMITY NECROSIS 2 0.0011
242 ANKYLOSING SPONDYLITIS 15 0.0011
243 SINUS TACHYCARDIA 16 0.0011
244 WHITE BLOOD CELL DISORDER 3 0.0011
245 SKIN WEEPING 4 0.0011
246 PYODERMA GANGRENOSUM 4 0.0011
247 BLOOD URINE PRESENT 21 0.0011
248 SUBDURAL HAEMORRHAGE 3 0.0011
249 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
250 THROMBOCYTOSIS 4 0.0011
251 HAEMOGLOBIN ABNORMAL 7 0.0011
252 ACUTE CORONARY SYNDROME 9 0.0011
253 CARDIAC FLUTTER 7 0.0011
254 DIFFUSE ALOPECIA 2 0.0011
255 DRUG TOLERANCE DECREASED 3 0.0011
256 ADENOCARCINOMA OF COLON 2 0.0011
257 BLOOD TEST ABNORMAL 15 0.0011
258 CYSTOID MACULAR OEDEMA 2 0.0011
259 NEUTROPHIL COUNT ABNORMAL 3 0.0011
260 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
261 VITAMIN B12 DECREASED 3 0.0010
262 PLEURAL EFFUSION 63 0.0010
263 ABDOMINAL WALL HAEMATOMA 2 0.0010
264 THORACIC VERTEBRAL FRACTURE 3 0.0010
265 BLOOD IRON DECREASED 12 0.0010
266 CELL DEATH 2 0.0010
267 HAEMORRHAGE INTRACRANIAL 15 0.0010
268 PERICARDIAL EFFUSION 23 0.0010
269 PLATELET COUNT ABNORMAL 6 0.0010
270 KLEBSIELLA INFECTION 5 0.0010
271 SUBARACHNOID HAEMORRHAGE 10 0.0010
272 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
273 ESCHERICHIA INFECTION 8 0.0010
274 BASAL CELL CARCINOMA 15 0.0010
275 TRANSFUSION 10 0.0010
276 GINGIVAL BLEEDING 13 0.0010
277 THROMBOCYTOPENIA 106 0.0009
278 HAEMATOTOXICITY 9 0.0009
279 RASH MACULAR 33 0.0009
280 HYDRONEPHROSIS 7 0.0009
281 FEBRILE NEUTROPENIA 62 0.0009
282 PSEUDOMONAS INFECTION 8 0.0009
283 BACTERIAL SEPSIS 3 0.0009
284 OTITIS MEDIA 3 0.0009
285 COLONOSCOPY 2 0.0009
286 HAEMOLYSIS 7 0.0009
287 EYE HAEMORRHAGE 12 0.0009
288 MYELODYSPLASTIC SYNDROME 13 0.0009
289 THERAPY PARTIAL RESPONDER 14 0.0009
290 HAEMORRHAGIC STROKE 7 0.0009
291 CEREBRAL HAEMATOMA 3 0.0009
292 CHRONIC GASTRITIS 2 0.0009
293 SUSPECTED OFF LABEL USE 4 0.0009
294 B-CELL LYMPHOMA 3 0.0009
295 BLOOD LOSS ANAEMIA 2 0.0009
296 SKIN CANCER 19 0.0009
297 LEUKOPENIA 44 0.0009
298 IMMUNODEFICIENCY 13 0.0009
299 APLASIA PURE RED CELL 3 0.0009
300 ONYCHOCLASIS 6 0.0009
301 CYTOMEGALOVIRUS COLITIS 2 0.0009
302 LOCALISED OEDEMA 4 0.0009
303 HEPATIC CYTOLYSIS 11 0.0009
304 AGRANULOCYTOSIS 16 0.0009
305 SKIN ULCER 22 0.0009
306 SQUAMOUS CELL CARCINOMA 8 0.0008
307 HAEMATOMA 22 0.0008
308 COLORECTAL CANCER METASTATIC 2 0.0008
309 FULL BLOOD COUNT DECREASED 17 0.0008
310 CONJUNCTIVAL HYPERAEMIA 3 0.0008
311 PANCYTOPENIA 47 0.0008
312 HEPATITIS B 5 0.0008
313 BRAIN FOG 13 0.0008
314 CUTANEOUS VASCULITIS 3 0.0008
315 AMYLASE INCREASED 3 0.0008
316 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
317 WOUND HAEMORRHAGE 3 0.0008
318 HYPERCALCAEMIA 10 0.0008
319 HEPATIC FUNCTION ABNORMAL 30 0.0008
320 HAEMORRHAGE 84 0.0008
321 CATHETER SITE HAEMORRHAGE 2 0.0008
322 DERMATITIS EXFOLIATIVE 4 0.0008
323 IMMUNOSUPPRESSION 7 0.0008
324 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
325 BRAIN ABSCESS 2 0.0008
326 HAEMATURIA 27 0.0008
327 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
328 ABDOMINAL INFECTION 2 0.0008
329 HAEMARTHROSIS 7 0.0008
330 COVID-19 136 0.0008
331 REHABILITATION THERAPY 3 0.0008
332 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
333 RHINOVIRUS INFECTION 3 0.0008
334 SUBDURAL HAEMATOMA 11 0.0008
335 PROSTATOMEGALY 3 0.0008
336 HEPATIC FAILURE 23 0.0008
337 SKIN ODOUR ABNORMAL 3 0.0008
338 EXFOLIATIVE RASH 2 0.0008
339 NEUTROPENIA 103 0.0008
340 CORONAVIRUS INFECTION 5 0.0008
341 OESOPHAGEAL CANDIDIASIS 3 0.0008
342 SKIN MASS 5 0.0007
343 EPISTAXIS 56 0.0007
344 BLOOD SODIUM INCREASED 2 0.0007
345 BLOOD BILIRUBIN INCREASED 20 0.0007
346 SPINAL STENOSIS 3 0.0007
347 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
348 SECOND PRIMARY MALIGNANCY 6 0.0007
349 LEUKOCYTOSIS 13 0.0007
350 SKIN DISCOLOURATION 33 0.0007
351 MALNUTRITION 8 0.0007
352 MOUTH ULCERATION 15 0.0007
353 SKIN PLAQUE 6 0.0007
354 HOSPICE CARE 7 0.0007
355 HYPERPYREXIA 3 0.0007
356 PULMONARY TUBERCULOSIS 3 0.0007
357 RETINAL HAEMORRHAGE 5 0.0007
358 SKIN HYPERPIGMENTATION 6 0.0007
359 METASTATIC NEOPLASM 3 0.0007
360 SKIN ATROPHY 4 0.0007
361 BLOOD URIC ACID INCREASED 4 0.0007
362 HAEMOGLOBIN DECREASED 71 0.0007
363 RESPIRATORY TRACT INFECTION 18 0.0007
364 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
365 IMMOBILE 3 0.0007
366 MELANOCYTIC NAEVUS 3 0.0007
367 EAR DISCOMFORT 7 0.0007
368 TEMPERATURE INTOLERANCE 7 0.0007
369 CELLULITIS 34 0.0007
370 GASTROINTESTINAL INFECTION 6 0.0007
371 OFF LABEL USE 585 0.0007
372 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
373 CENTRAL VENOUS CATHETERISATION 2 0.0007
374 BONE MARROW DISORDER 2 0.0007
375 FULL BLOOD COUNT ABNORMAL 7 0.0007
376 URINE ABNORMALITY 3 0.0007
377 HAEMOGLOBIN INCREASED 3 0.0007
378 INGUINAL HERNIA 4 0.0007
379 UNDERDOSE 48 0.0007
380 DYSCHEZIA 2 0.0007
381 MALIGNANT NEOPLASM PROGRESSION 67 0.0007
382 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
383 PIGMENTATION DISORDER 4 0.0006
384 PRODUCT DISTRIBUTION ISSUE 6 0.0006
385 ATRIOVENTRICULAR BLOCK 5 0.0006
386 SKIN LACERATION 7 0.0006
387 PULMONARY HAEMORRHAGE 5 0.0006
388 SKIN ABRASION 3 0.0006
389 BLOOD ALBUMIN DECREASED 5 0.0006
390 VENTRICULAR FIBRILLATION 7 0.0006
391 INFECTION 90 0.0006
392 PNEUMONIA 201 0.0006
393 NIGHT SWEATS 20 0.0006
394 SEPTIC SHOCK 27 0.0006
395 GUILLAIN-BARRE SYNDROME 3 0.0006
396 HERPES SIMPLEX 4 0.0006
397 BACK DISORDER 10 0.0006
398 PLATELET COUNT INCREASED 8 0.0006
399 HEPATOMEGALY 6 0.0006
400 DEAFNESS NEUROSENSORY 2 0.0006
401 STAPHYLOCOCCAL SEPSIS 3 0.0006
402 WALKING AID USER 4 0.0006
403 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
404 APPETITE DISORDER 4 0.0006
405 ELECTROLYTE IMBALANCE 7 0.0006
406 POST PROCEDURAL HAEMORRHAGE 7 0.0006
407 MENINGITIS 4 0.0006
408 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
409 BRONCHIECTASIS 4 0.0006
410 BACTERAEMIA 7 0.0006
411 PNEUMONITIS 16 0.0006
412 CEREBRAL HAEMORRHAGE 21 0.0006
413 CHEST DISCOMFORT 60 0.0006
414 INCREASED UPPER AIRWAY SECRETION 3 0.0006
415 CARDIAC OPERATION 5 0.0006
416 VARICOSE VEIN 3 0.0006
417 CERVICAL VERTEBRAL FRACTURE 2 0.0006
418 BLOOD MAGNESIUM DECREASED 5 0.0006
419 BLOOD CREATININE ABNORMAL 2 0.0006
420 MUSCLE STRAIN 5 0.0006
421 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
422 ACUTE RESPIRATORY FAILURE 11 0.0006
423 LIVER INJURY 14 0.0006
424 SKIN DISORDER 19 0.0006
425 PRODUCTIVE COUGH 27 0.0006
426 GENERALISED OEDEMA 7 0.0006
427 SEASONAL ALLERGY 8 0.0006
428 INTENTIONAL DOSE OMISSION 16 0.0006
429 COMPRESSION FRACTURE 3 0.0006
430 PRODUCT SIZE ISSUE 3 0.0006
431 GINGIVITIS 3 0.0006
432 BLOOD PRESSURE ABNORMAL 11 0.0006
433 IMPAIRED HEALING 18 0.0005
434 DYSPHAGIA 52 0.0005
435 BLOOD PHOSPHORUS DECREASED 2 0.0005
436 PRODUCT PHYSICAL ISSUE 11 0.0005
437 VENTRICULAR TACHYCARDIA 9 0.0005
438 TOOTH FRACTURE 6 0.0005
439 HYPERKERATOSIS 3 0.0005
440 SENSITIVE SKIN 4 0.0005
441 ARTHROPOD BITE 4 0.0005
442 INTRACRANIAL PRESSURE INCREASED 3 0.0005
443 COLON CANCER 8 0.0005
444 SUNBURN 4 0.0005
445 BACTERIAL INFECTION 10 0.0005
446 ANGIOPATHY 3 0.0005
447 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
448 INTESTINAL PERFORATION 6 0.0005
449 CANDIDA INFECTION 9 0.0005
450 GRANULOCYTOPENIA 3 0.0005
451 TROPONIN INCREASED 4 0.0005
452 CHOLECYSTECTOMY 6 0.0005
453 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
454 NEOPLASM 6 0.0005
455 PERIPHERAL SWELLING 80 0.0005
456 STRESS CARDIOMYOPATHY 3 0.0005
457 SKIN WARM 3 0.0005
458 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
459 CARDIOPULMONARY FAILURE 2 0.0005
460 SEPSIS 57 0.0005
461 DRUG-INDUCED LIVER INJURY 16 0.0005
462 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
463 PLEURISY 3 0.0005
464 SINUS HEADACHE 3 0.0005
465 CARDIAC PACEMAKER INSERTION 3 0.0005
466 MASS 7 0.0005
467 OEDEMA PERIPHERAL 61 0.0005
468 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
469 BLEPHARITIS 2 0.0005
470 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
471 TRANSAMINASES INCREASED 11 0.0005
472 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
473 DERMATITIS ACNEIFORM 3 0.0005
474 DRY THROAT 5 0.0005
475 RENAL IMPAIRMENT 41 0.0005
476 RASH 212 0.0005
477 HYPOXIA 17 0.0005
478 VENTRICULAR EXTRASYSTOLES 5 0.0005
479 GASTROINTESTINAL DISORDER 43 0.0005
480 INFUSION SITE SWELLING 3 0.0005
481 PERICARDITIS 8 0.0005
482 BLOOD CREATININE INCREASED 31 0.0005
483 LABORATORY TEST ABNORMAL 14 0.0005
484 CARDIAC FAILURE 38 0.0005
485 BUNDLE BRANCH BLOCK LEFT 2 0.0005
486 HERNIA 9 0.0005
487 WOUND 13 0.0005
488 BRADYPHRENIA 3 0.0005
489 BLOOD CALCIUM INCREASED 4 0.0005
490 PRODUCT FORMULATION ISSUE 3 0.0005
491 HAEMATOCRIT DECREASED 9 0.0005
492 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
493 BLOOD CREATINE INCREASED 2 0.0005
494 DRUG ERUPTION 8 0.0005
495 HYPERTENSIVE CRISIS 5 0.0004
496 HAIR TEXTURE ABNORMAL 6 0.0004
497 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
498 RASH PAPULAR 10 0.0004
499 PYREXIA 154 0.0004
500 OROPHARYNGEAL DISCOMFORT 4 0.0004
501 BODY TEMPERATURE INCREASED 9 0.0004
502 RESPIRATORY TRACT CONGESTION 7 0.0004
503 HERPES ZOSTER 25 0.0004
504 URINARY TRACT INFECTION 74 0.0004
505 NERVE COMPRESSION 4 0.0004
506 HYPERTRANSAMINASAEMIA 3 0.0004
507 ARTHRITIS INFECTIVE 2 0.0004
508 BONE PAIN 25 0.0004
509 LEUKAEMIA 4 0.0004
510 THERMAL BURN 3 0.0004
511 PRODUCT SUPPLY ISSUE 3 0.0004
512 FUNGAL INFECTION 14 0.0004
513 POOR QUALITY SLEEP 9 0.0004
514 FACE OEDEMA 7 0.0004
515 FAECES SOFT 3 0.0004
516 DIZZINESS POSTURAL 4 0.0004
517 ADRENAL INSUFFICIENCY 5 0.0004
518 NEUROPATHY PERIPHERAL 39 0.0004
519 ASTHENIA 154 0.0004
520 ORAL DISORDER 3 0.0004
521 KIDNEY INFECTION 8 0.0004
522 VITREOUS FLOATERS 4 0.0004
523 PULMONARY MASS 6 0.0004
524 SLUGGISHNESS 4 0.0004
525 HIP ARTHROPLASTY 6 0.0004
526 PROCEDURAL COMPLICATION 3 0.0004
527 GOUT 7 0.0004
528 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
529 CEREBRAL ISCHAEMIA 2 0.0004
530 POOR VENOUS ACCESS 4 0.0004
531 ACUTE MYELOID LEUKAEMIA 6 0.0004
532 STOMATITIS 23 0.0004
533 SCRATCH 4 0.0004
534 PNEUMOTHORAX 6 0.0004
535 SUDDEN DEATH 4 0.0004
536 RENAL CYST 3 0.0004
537 RENAL PAIN 4 0.0004
538 ASCITES 11 0.0004
539 NEOPLASM PROGRESSION 13 0.0004
540 INTERSTITIAL LUNG DISEASE 18 0.0004
541 ANAL ABSCESS 2 0.0004
542 NEURALGIA 9 0.0004
543 CHEILITIS 2 0.0004
544 BLOOD POTASSIUM INCREASED 6 0.0004
545 TACHYPNOEA 5 0.0004
546 COUGH 103 0.0004
547 ABNORMAL FAECES 3 0.0004
548 DEAFNESS UNILATERAL 2 0.0004
549 EMBOLISM 3 0.0004
550 HEMIPLEGIA 3 0.0004
551 PRODUCT DOSE OMISSION ISSUE 106 0.0004
552 HAEMOPTYSIS 10 0.0004
553 INFUSION SITE ERYTHEMA 3 0.0004
554 CARDIAC VALVE DISEASE 2 0.0003
555 MUSCULOSKELETAL DISCOMFORT 6 0.0003
556 CARDIAC MURMUR 3 0.0003
557 SKIN SWELLING 3 0.0003
558 NAIL DISORDER 3 0.0003
559 MYALGIA 58 0.0003
560 EAR INFECTION 9 0.0003
561 RESPIRATORY RATE INCREASED 3 0.0003
562 ARRHYTHMIA 16 0.0003
563 CATARACT OPERATION 2 0.0003
564 CATARACT 20 0.0003
565 HYPERLIPIDAEMIA 4 0.0003
566 POLYNEUROPATHY 4 0.0003
567 BLOOD PRESSURE INCREASED 51 0.0003
568 LIMB INJURY 9 0.0003
569 LOCALISED INFECTION 8 0.0003
570 OSTEOPENIA 5 0.0003
571 HYPERGLYCAEMIA 12 0.0003
572 PATHOGEN RESISTANCE 3 0.0003
573 RESPIRATORY FAILURE 24 0.0003
574 JOINT INJURY 7 0.0003
575 HAEMATOCHEZIA 18 0.0003
576 SMALL INTESTINAL OBSTRUCTION 4 0.0003
577 TOOTH EXTRACTION 4 0.0003
578 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
579 FLANK PAIN 3 0.0003
580 FATIGUE 249 0.0003
581 SECRETION DISCHARGE 4 0.0003
582 BLOOD SODIUM DECREASED 6 0.0003
583 SPUTUM DISCOLOURED 3 0.0003
584 MUSCLE ATROPHY 4 0.0003
585 RASH PRURITIC 17 0.0003
586 AFFECT LABILITY 3 0.0003
587 HIATUS HERNIA 4 0.0003
588 EAR PAIN 6 0.0003
589 ANGINA UNSTABLE 2 0.0003
590 HYPERTENSION 65 0.0003
591 DEAFNESS 8 0.0003
592 KNEE OPERATION 3 0.0003
593 PULMONARY CONGESTION 4 0.0003
594 LIGAMENT SPRAIN 3 0.0003
595 SARS-COV-2 TEST POSITIVE 4 0.0003
596 BLADDER DISORDER 3 0.0003
597 CARDIAC FAILURE ACUTE 2 0.0003
598 MALIGNANT MELANOMA 4 0.0003
599 APHASIA 9 0.0003
600 EMPHYSEMA 3 0.0003
601 SINUS CONGESTION 4 0.0003
602 HEMIPARESIS 5 0.0003
603 UVEITIS 4 0.0003
604 RHINORRHOEA 19 0.0003
605 INITIAL INSOMNIA 3 0.0003
606 DROOLING 2 0.0003
607 ENCEPHALITIS 2 0.0003
608 EYE DISCHARGE 3 0.0003
609 BACK PAIN 67 0.0003
610 POLLAKIURIA 12 0.0003
611 DIARRHOEA 185 0.0003
612 DEFAECATION URGENCY 2 0.0003
613 KNEE ARTHROPLASTY 6 0.0003
614 HYPONATRAEMIA 16 0.0003
615 DEPRESSED MOOD 15 0.0003
616 NEPHROLITHIASIS 13 0.0003
617 SLEEP DISORDER 20 0.0003
618 LYMPHOPENIA 4 0.0003
619 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
620 HEAD DISCOMFORT 5 0.0003
621 CONSTIPATION 61 0.0003
622 CARDIOGENIC SHOCK 4 0.0003
623 FAECES DISCOLOURED 6 0.0003
624 DECREASED APPETITE 64 0.0003
625 DYSPEPSIA 27 0.0003
626 EYE DISORDER 9 0.0003
627 PALPITATIONS 32 0.0003
628 SURGERY 16 0.0003
629 ERECTILE DYSFUNCTION 7 0.0003
630 DRUG RESISTANCE 7 0.0003
631 DYSURIA 10 0.0003
632 BLOOD GLUCOSE ABNORMAL 5 0.0003
633 TOOTH DISORDER 6 0.0003
634 ABDOMINAL DISTENSION 28 0.0003
635 ECZEMA 14 0.0003
636 RESPIRATORY DISORDER 8 0.0003
637 MUSCULOSKELETAL PAIN 14 0.0003
638 JOINT STIFFNESS 7 0.0003
639 HEPATIC CIRRHOSIS 5 0.0003
640 CHROMATURIA 6 0.0003
641 COLITIS 10 0.0003
642 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
643 SCAB 3 0.0003
644 MYOCARDITIS 3 0.0003
645 EPILEPSY 8 0.0003
646 INCREASED APPETITE 5 0.0003
647 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
648 NASOPHARYNGITIS 48 0.0003
649 DRUG INTOLERANCE 25 0.0003
650 APHTHOUS ULCER 2 0.0003
651 VASCULITIS 3 0.0003
652 SKIN FISSURES 5 0.0003
653 HYPOACUSIS 11 0.0003
654 SINUS DISORDER 5 0.0003
655 MACULAR DEGENERATION 3 0.0003
656 NECK PAIN 14 0.0003
657 SPINAL FRACTURE 5 0.0002
658 BLISTER 14 0.0002
659 OROPHARYNGEAL PAIN 23 0.0002
660 BURSITIS 3 0.0002
661 FLATULENCE 14 0.0002
662 DECUBITUS ULCER 2 0.0002
663 DEATH 211 0.0002
664 SPINAL OPERATION 3 0.0002
665 ACUTE KIDNEY INJURY 37 0.0002
666 CYST 3 0.0002
667 ARTHRITIS 19 0.0002
668 INFUSION RELATED REACTION 16 0.0002
669 ABDOMINAL PAIN 56 0.0002
670 VIRAL INFECTION 8 0.0002
671 COAGULOPATHY 4 0.0002
672 URINARY RETENTION 8 0.0002
673 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
674 OEDEMA 13 0.0002
675 CHILLS 28 0.0002
676 DERMATITIS 5 0.0002
677 ABDOMINAL DISCOMFORT 40 0.0002
678 ARTHRALGIA 99 0.0002
679 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
680 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
681 PRURITUS 91 0.0002
682 HAEMATEMESIS 6 0.0002
683 FLUID RETENTION 12 0.0002
684 DRUG INTERACTION 37 0.0002
685 LIVER FUNCTION TEST INCREASED 5 0.0002
686 RECTAL HAEMORRHAGE 10 0.0002
687 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
688 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
689 PAIN IN EXTREMITY 68 0.0002
690 ORAL CANDIDIASIS 3 0.0002
691 IMMUNE SYSTEM DISORDER 3 0.0002
692 TOOTH INFECTION 3 0.0002
693 LIMB DISCOMFORT 7 0.0002
694 RASH MACULO-PAPULAR 5 0.0002
695 THROMBOSIS 18 0.0002
696 ORAL PAIN 5 0.0002
697 THROAT IRRITATION 10 0.0002
698 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
699 HOSPITALISATION 34 0.0002
700 RESTLESS LEGS SYNDROME 4 0.0002
701 SYNCOPE 22 0.0002
702 PRODUCT AVAILABILITY ISSUE 5 0.0002
703 ERYTHEMA 45 0.0002
704 DIZZINESS 109 0.0002
705 PERIPHERAL COLDNESS 3 0.0002
706 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
707 DIVERTICULITIS 6 0.0002
708 ORAL DISCOMFORT 3 0.0002
709 APHONIA 3 0.0002
710 HEPATIC STEATOSIS 4 0.0002
711 DEMENTIA 6 0.0002
712 RENAL DISORDER 10 0.0002
713 FALL 71 0.0002
714 DISCOMFORT 13 0.0002
715 MUSCLE SPASMS 39 0.0002
716 DYSPNOEA EXERTIONAL 8 0.0002
717 UNEVALUABLE EVENT 16 0.0002
718 DIALYSIS 3 0.0002
719 PROSTATE CANCER 17 0.0002
720 FRACTURE 4 0.0002
721 MUSCULAR WEAKNESS 24 0.0002
722 RENAL FAILURE 28 0.0002
723 PROTEINURIA 4 0.0002
724 GAIT INABILITY 7 0.0002
725 ANGINA PECTORIS 6 0.0002
726 MOBILITY DECREASED 15 0.0002
727 PARAESTHESIA ORAL 3 0.0002
728 ATELECTASIS 2 0.0002
729 CARDIAC ARREST 17 0.0002
730 CEREBRAL INFARCTION 5 0.0002
731 ILLNESS 21 0.0002
732 ENCEPHALOPATHY 5 0.0002
733 ACUTE MYOCARDIAL INFARCTION 6 0.0002
734 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
735 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
736 HEART RATE INCREASED 20 0.0002
737 PULMONARY OEDEMA 9 0.0002
738 LACRIMATION INCREASED 6 0.0002
739 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
740 INFLUENZA 22 0.0002
741 TASTE DISORDER 4 0.0002
742 NAUSEA 156 0.0002
743 VERTIGO 12 0.0002
744 DIABETES MELLITUS 15 0.0002
745 DRUG LEVEL DECREASED 2 0.0002
746 TINNITUS 9 0.0002
747 NEOPLASM MALIGNANT 13 0.0002
748 THYROID DISORDER 3 0.0002
749 EMOTIONAL DISORDER 6 0.0002
750 CYANOSIS 3 0.0002
751 JOINT SWELLING 23 0.0002
752 CHEST PAIN 35 0.0002
753 CYSTITIS 6 0.0002
754 RASH ERYTHEMATOUS 9 0.0002
755 SCIATICA 3 0.0002
756 SENSORY DISTURBANCE 3 0.0002
757 HIP FRACTURE 6 0.0002
758 PAIN OF SKIN 5 0.0002
759 BACK INJURY 2 0.0002
760 ALOPECIA 36 0.0002
761 MUSCULOSKELETAL STIFFNESS 16 0.0002
762 ASPIRATION 2 0.0002
763 PHOTOSENSITIVITY REACTION 3 0.0002
764 DRY EYE 9 0.0002
765 FEELING COLD 5 0.0002
766 HYPOTENSION 36 0.0002
767 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
768 THERAPY NON-RESPONDER 8 0.0002
769 EYE INFECTION 2 0.0002
770 DYSPNOEA 100 0.0002
771 CIRCULATORY COLLAPSE 3 0.0002
772 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
773 SINUSITIS 18 0.0002
774 BRONCHITIS 13 0.0002
775 PRODUCT USE ISSUE 33 0.0002
776 DERMATITIS CONTACT 2 0.0002
777 SCAR 3 0.0002
778 HYPERSOMNIA 5 0.0002
779 SHOCK 4 0.0002
780 MUSCLE TWITCHING 4 0.0002
781 ORTHOSTATIC HYPOTENSION 3 0.0002
782 LIVER FUNCTION TEST ABNORMAL 5 0.0002
783 HEART RATE DECREASED 6 0.0002
784 COLD SWEAT 3 0.0002
785 URINARY INCONTINENCE 5 0.0002
786 ATAXIA 2 0.0002
787 DISEASE RECURRENCE 8 0.0002
788 ISCHAEMIC STROKE 3 0.0002
789 VOMITING 79 0.0002
790 CHOLECYSTITIS 2 0.0002
791 ACCIDENT 2 0.0002
792 HEADACHE 105 0.0002
793 MEMORY IMPAIRMENT 23 0.0002
794 HYPERSENSITIVITY 31 0.0002
795 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
796 BLOOD POTASSIUM DECREASED 5 0.0002
797 TOOTHACHE 3 0.0002
798 CORONARY ARTERY DISEASE 5 0.0002
799 MENTAL IMPAIRMENT 4 0.0002
800 PRESYNCOPE 4 0.0002
801 LUNG DISORDER 8 0.0002
802 GAIT DISTURBANCE 31 0.0002
803 BALANCE DISORDER 14 0.0002
804 CONJUNCTIVITIS 3 0.0002
805 INSOMNIA 43 0.0002
806 HEPATIC ENZYME INCREASED 11 0.0002
807 WEIGHT DECREASED 45 0.0002
808 AGEUSIA 4 0.0002
809 CARDIAC DISORDER 15 0.0002
810 SWELLING 15 0.0002
811 OXYGEN SATURATION DECREASED 9 0.0002
812 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
813 DERMATITIS ALLERGIC 2 0.0002
814 BRAIN OEDEMA 2 0.0002
815 FOOT FRACTURE 3 0.0002
816 PRODUCT COMPLAINT 4 0.0002
817 MUSCULOSKELETAL DISORDER 3 0.0002
818 HEPATITIS 4 0.0002
819 LOWER LIMB FRACTURE 3 0.0002
820 ERUCTATION 3 0.0002
821 PAIN 95 0.0002
822 AMNESIA 10 0.0002
823 ORAL HERPES 3 0.0002
824 MUCOSAL INFLAMMATION 4 0.0002
825 CHOLELITHIASIS 5 0.0002
826 STAPHYLOCOCCAL INFECTION 5 0.0002
827 DEHYDRATION 20 0.0001
828 COGNITIVE DISORDER 7 0.0001
829 DRY SKIN 20 0.0001
830 EYE PRURITUS 5 0.0001
831 JAUNDICE 4 0.0001
832 TYPE 2 DIABETES MELLITUS 5 0.0001
833 FEEDING DISORDER 3 0.0001
834 ACUTE HEPATIC FAILURE 2 0.0001
835 OSTEOPOROSIS 6 0.0001
836 RIB FRACTURE 3 0.0001
837 CORONARY ARTERY OCCLUSION 2 0.0001
838 VISION BLURRED 20 0.0001
839 CHRONIC KIDNEY DISEASE 11 0.0001
840 MENTAL STATUS CHANGES 4 0.0001
841 ARTHROPATHY 8 0.0001
842 WEIGHT INCREASED 32 0.0001
843 CARPAL TUNNEL SYNDROME 2 0.0001
844 HYPERKALAEMIA 5 0.0001
845 BLINDNESS UNILATERAL 2 0.0001
846 EATING DISORDER 3 0.0001
847 THERAPY INTERRUPTED 10 0.0001
848 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
849 BLOOD GLUCOSE INCREASED 26 0.0001
850 NO ADVERSE EVENT 25 0.0001
851 APATHY 2 0.0001
852 DYSPHONIA 8 0.0001
853 MELAENA 3 0.0001
854 ABDOMINAL PAIN UPPER 28 0.0001
855 INFLAMMATION 7 0.0001
856 TACHYCARDIA 12 0.0001
857 HEPATOTOXICITY 3 0.0001
858 SNEEZING 3 0.0001
859 HEART RATE IRREGULAR 3 0.0001
860 TREMOR 22 0.0001
861 BLOOD COUNT ABNORMAL 2 0.0001
862 FEELING HOT 8 0.0001
863 SKIN EXFOLIATION 11 0.0001
864 DEVICE RELATED INFECTION 2 0.0001
865 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
866 VISUAL IMPAIRMENT 16 0.0001
867 EJECTION FRACTION DECREASED 2 0.0001
868 NERVOUS SYSTEM DISORDER 4 0.0001
869 HEAD INJURY 4 0.0001
870 DISORIENTATION 5 0.0001
871 BLOOD PRESSURE FLUCTUATION 3 0.0001
872 DRY MOUTH 10 0.0001
873 DEEP VEIN THROMBOSIS 8 0.0001
874 INFLUENZA LIKE ILLNESS 10 0.0001
875 VISUAL ACUITY REDUCED 4 0.0001
876 PNEUMONIA ASPIRATION 3 0.0001
877 ROAD TRAFFIC ACCIDENT 5 0.0001
878 BLOOD UREA INCREASED 2 0.0001
879 NASAL CONGESTION 7 0.0001
880 CARDIOVASCULAR DISORDER 3 0.0001
881 CEREBROVASCULAR ACCIDENT 20 0.0001
882 DRUG INEFFECTIVE 155 0.0001
883 HYPOPHAGIA 3 0.0001
884 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
885 DELIRIUM 4 0.0001
886 CONDITION AGGRAVATED 35 0.0001
887 EOSINOPHILIA 2 0.0001
888 GASTRITIS 3 0.0001
889 HYPOAESTHESIA 17 0.0001
890 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
891 ADVERSE DRUG REACTION 10 0.0001
892 FREQUENT BOWEL MOVEMENTS 3 0.0001
893 MOOD ALTERED 3 0.0001
894 BONE DISORDER 2 0.0001
895 MALAISE 48 0.0001
896 ACCIDENTAL OVERDOSE 4 0.0001
897 SOMNOLENCE 22 0.0001
898 RESPIRATORY DISTRESS 3 0.0001
899 PROCEDURAL PAIN 3 0.0001
900 PARAESTHESIA 17 0.0001
901 SWELLING FACE 7 0.0001
902 EYE PAIN 6 0.0001
903 HOT FLUSH 8 0.0001
904 INTESTINAL OBSTRUCTION 4 0.0001
905 PAIN IN JAW 3 0.0001
906 OCULAR HYPERAEMIA 5 0.0001
907 FEELING ABNORMAL 25 0.0001
908 EYE IRRITATION 6 0.0001
909 DYSSTASIA 3 0.0001
910 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
911 CHOKING 2 0.0001
912 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
913 RENAL INJURY 3 0.0001
914 BURNING SENSATION 7 0.0001
915 BLINDNESS 4 0.0001
916 ADVERSE EVENT 9 0.0001
917 FEMUR FRACTURE 3 0.0001
918 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
919 NERVOUSNESS 5 0.0001
920 SPEECH DISORDER 5 0.0001
921 WITHDRAWAL SYNDROME 4 0.0001
922 PANCREATITIS 5 0.0001
923 OSTEOARTHRITIS 4 0.0001
924 BRADYCARDIA 5 0.0001
925 MOOD SWINGS 3 0.0001
926 MOVEMENT DISORDER 3 0.0001
927 VAGINAL HAEMORRHAGE 4 0.0001
928 MENTAL DISORDER 4 0.0001
929 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
930 BLOOD PRESSURE DECREASED 6 0.0001
931 ANGER 3 0.0001
932 CONFUSIONAL STATE 14 0.0001
933 SEIZURE 10 0.0001
934 BLOOD CHOLESTEROL INCREASED 4 0.0001
935 INJURY 6 0.0001
936 ANXIETY 24 0.0001
937 COMA 4 0.0001
938 URTICARIA 14 0.0001
939 IRRITABILITY 5 0.0001
940 EYE SWELLING 3 0.0001
941 ABDOMINAL PAIN LOWER 2 0.0001
942 HYPERHIDROSIS 10 0.0001
943 BREAST CANCER FEMALE 2 0.0001
944 CARDIAC FAILURE CONGESTIVE 6 0.0001
945 MIGRAINE 7 0.0001
946 ABNORMAL DREAMS 2 0.0001
947 TREATMENT FAILURE 6 0.0001
948 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
949 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
950 ANGIOEDEMA 3 0.0001
951 LIVER DISORDER 3 0.0001
952 DYSGEUSIA 5 0.0001
953 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
954 SKIN IRRITATION 3 0.0001
955 PULMONARY EMBOLISM 6 0.0001
956 LOSS OF CONSCIOUSNESS 8 0.0001
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
958 TOXICITY TO VARIOUS AGENTS 10 0.0001
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
960 THERAPY CESSATION 3 0.0001
961 MYOCARDIAL INFARCTION 10 0.0001
962 DEPRESSION 13 0.0001
963 PRODUCT STORAGE ERROR 5 0.0001
964 INCORRECT DOSE ADMINISTERED 13 0.0001
965 INJECTION SITE ERYTHEMA 7 0.0001
966 DISTURBANCE IN ATTENTION 3 0.0001
967 CRYING 2 0.0001
968 TREATMENT NONCOMPLIANCE 3 0.0001
969 WHEEZING 3 0.0001
970 ABNORMAL BEHAVIOUR 2 0.0001
971 INJECTION SITE BRUISING 4 0.0001
972 DYSKINESIA 2 0.0000
973 OVERDOSE 10 0.0000
974 SKIN BURNING SENSATION 3 0.0000
975 BLOOD GLUCOSE DECREASED 2 0.0000
976 AGITATION 3 0.0000
977 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
978 AGGRESSION 2 0.0000
979 HALLUCINATION 3 0.0000
980 ACNE 3 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
982 INJECTION SITE SWELLING 3 0.0000
983 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
984 COMPLETED SUICIDE 3 0.0000
985 ASTHMA 4 0.0000
986 FLUSHING 3 0.0000
987 RHEUMATOID ARTHRITIS 3 0.0000
988 EMOTIONAL DISTRESS 3 0.0000
989 PSORIASIS 3 0.0000
990 BREAST CANCER 2 0.0000